Status epilepticus and Left ventricular hypertrophy

Summary:

Left ventricular hypertrophy is found among people with Status epilepticus, especially for people who are female, 50-59 old.

The study analyzes which people have Left ventricular hypertrophy with Status epilepticus. It is created by eHealthMe based on reports of 48 people who have Status epilepticus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 671 drugs and 948 conditions by eHealthMe. Check the latest studies of Status epilepticus.

What is Left ventricular hypertrophy?

Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart) is found to be associated with 899 drugs and 755 conditions by eHealthMe. Check the latest studies of Left ventricular hypertrophy.

On Jul, 10, 2026

48 people who have Status Epilepticus and Left Ventricular Hypertrophy are studied.

Would you have Left ventricular hypertrophy when you have Status epilepticus?

Gender of people who have Status Epilepticus and experienced Left Ventricular Hypertrophy *:

female: 100 %
male: 0.0 %

Age of people who have Status Epilepticus and experienced Left Ventricular Hypertrophy *:

Common co-existing conditions for these people *:

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 43 people, 89.58%
Appendicitis (inflammation of the appendix): 28 people, 58.33%
Electroencephalogram Abnormal: 17 people, 35.42%
Anaesthesia: 8 people, 16.67%
Type 2 Diabetes: 1 person, 2.08%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.08%
High Blood Pressure: 1 person, 2.08%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 2.08%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 2.08%
Arrhythmias (irregular heartbeat): 1 person, 2.08%

Common drugs taken by these people *:

Forane: 34 people, 70.83%
Tegretol: 27 people, 56.25%
Midazolam: 24 people, 50.00%
Keppra: 21 people, 43.75%
Piperacillin And Tazobactam: 13 people, 27.08%
Valproic Acid: 8 people, 16.67%
Isoflurane: 8 people, 16.67%
Levetiracetam: 8 people, 16.67%
Methylprednisolone: 8 people, 16.67%
Phenytoin: 8 people, 16.67%

Common symptoms for these people *:

Hypotension (abnormally low blood pressure): 46 people, 95.83%
Enlarged Heart: 45 people, 93.75%
Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 45 people, 93.75%
Intestinal Ischaemia (decreased supply of oxygenated blood to the intestines): 45 people, 93.75%
Intra-Abdominal Pressure Increased: 44 people, 91.67%
Pneumatosis (air or gas in an abnormal location in the body): 44 people, 91.67%
Necrosis Ischaemic (death of cell due to lack of blood supply): 44 people, 91.67%
Abdominal Distension: 41 people, 85.42%
Nausea And Vomiting: 41 people, 85.42%
Abscess (pus): 35 people, 72.92%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Left ventricular hypertrophy?

- Check whether Left ventricular hypertrophy is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Left ventricular hypertrophy and Status epilepticus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.